FDA's Approval Process of Controversial Alzheimer's Drug Was 'Rife With Irregularities': Congressional Probe
The U.S. Food and Drug Administration's (FDA) approval process of the controversial and costly new Alzheimer’s drug Aduhelm was "rife with irregularities" ...
Source: theepochtimes.com